ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,945Medicare Part D Prescriptions Filled, Including Refills

Rank: 88 out of 1448

$464K Total Retail Price of All Prescriptions

Rank: 158 out of 1448

605 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CARVEDILOL 948 908 1 1
LISINOPRIL 620 603 2 5
LOVAZA 608 548 3 39
METOPROLOL SUCCINATE 573 544 4 6
AMLODIPINE BESYLATE 494 492 5 2
LOVASTATIN 364 362 6 35
SIMVASTATIN 356 339 7 3
ISOSORBIDE MONONITRATE ER 271 264 8 16
LOSARTAN POTASSIUM 270 270 9 11
WARFARIN SODIUM 268 264 10 8
CLOPIDOGREL 256 239 11 10
FUROSEMIDE 248 246 12 7
ATORVASTATIN CALCIUM 245 204 13 4
SPIRONOLACTONE 244 241 14 24
DIOVAN 224 213 15 15
AMIODARONE HCL 216 216 16 22
RANEXA 210 202 17 37
CRESTOR 206 189 18 17
PLAVIX 184 175 19 14
PRADAXA 142 142 20 27
SPIRONOLACTONE-HCTZ 122 110 21 114
TORSEMIDE 120 120 22 117
NITROSTAT 112 108 23 31
HYDROCHLOROTHIAZIDE 92 92 24 18
DIGOXIN 90 90 25 13
ATENOLOL 67 67 26 12
NITROGLYCERIN PATCH 58 55 27 98
TRILIPIX 54 54 28 86
PRAVASTATIN SODIUM 54 50 28 20
ZETIA 53 53 30 28
FENOFIBRATE 52 38 31 54
BENICAR 51 51 32 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 28, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.